Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 12, 2021
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
Thu, February 11, 2021
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
[ Thu, Feb 11th 2021
] - WOPRAI
Martin Auster Maintained (ALXO) at Buy with Increased Target to $98 on, Feb 11th, 2021
Martin Auster of Credit Suisse, Maintained "ALX Oncology Holdings Inc." (ALXO) at Buy with Increased Target from $62 to $98 on, Feb 11th, 2021.
Martin has made no other calls on ALXO in the last 4 months.
There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, 0 agree with Martin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Martin
- Swayampakula Ramakanth of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $100 on, Wednesday, February 10th, 2021
